AC Immune (ACIU) Enterprise Value Growth (3y) (2017 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.50% |
| Sep 30, 2025 | -26.62% |
| Jun 30, 2025 | -14.32% |
| Mar 31, 2025 | 4.89% |
| Dec 31, 2024 | 26.01% |
| Sep 30, 2024 | 34.40% |
| Jun 30, 2024 | -11.56% |
| Mar 31, 2024 | 91.87% |
| Dec 31, 2023 | 8.19% |
| Sep 30, 2023 | 27.10% |
| Jun 30, 2023 | 26.46% |
| Mar 31, 2023 | 27.70% |
| Dec 31, 2022 | 0.69% |
| Sep 30, 2022 | 24.43% |
| Jun 30, 2022 | 91.84% |
| Mar 31, 2022 | -2.88% |
| Dec 31, 2021 | -775.86% |
| Dec 31, 2020 | -18.76% |
| Sep 30, 2020 | -11.45% |
| Jun 30, 2020 | -7.99% |
| Mar 31, 2020 | -27.83% |
| Dec 31, 2019 | 5.14% |
| Sep 30, 2019 | 0.28% |
| Jun 30, 2019 | -993.55% |
| Dec 31, 2018 | -34.31% |
| Dec 31, 2017 | -232.47% |